Lenny van Bon

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Lenny van Bon, Alsya J. Affandi, Jasper Broen et al. · New England Journal of Medicine · 2013 · 454 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression

Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen et al. · PLoS ONE · 2009 · 180 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis

Zana Brkić, Lenny van Bon, Marta Cossu et al. · Annals of the Rheumatic Diseases · 2015 · 174 citations

Medicine, Immunology, Pathology +17

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes

Timothy R. D. J. Radstake, Lenny van Bon, Jasper Broen et al. · PLoS ONE · 2009 · 173 citations · Full text

Life Sciences, Immunology, Pathology +17

Association of MicroRNA‐618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis

Marzia Rossato, Alsya J. Affandi, Soley Thordardottir et al. · Arthritis & Rheumatology · 2017 · 73 citations · Full text

Life Sciences, Immunology, Pathology +17